Drug Report History

Return to report

Below you will find the report version history. When a report is updated, a new version of the report is created. The report history allows you to see the changes between versions. You can select two versions of the report to compare. The fields that were changed between versions will be highlighted in yellow.

The translation of reports creates two separate versions which is why some reports may not seem to have any differences. In this case, only the language field below will be highlighted in yellow.

Version v3-EN Version v2-FR
Language English French
Date Updated 2017-06-16 2017-06-15
Drug Identification Number 00622133 00622133
Brand name DILAUDID HP DILAUDID HP
Common or Proper name Hydromorphone Hydromorphone
Company Name PURDUE PHARMA PURDUE PHARMA
Ingredients HYDROMORPHONE HYDROCHLORIDE HYDROMORPHONE HYDROCHLORIDE
Strength(s) 10MG 10MG
Dosage form(s) LIQUID LIQUID
Route of administration INTRAMUSCULAR INTRAVENOUS SUBCUTANEOUS INTRAMUSCULAR INTRAVENOUS SUBCUTANEOUS
Packaging size 10 x 1 mL ampoules 10 x 1 mL ampoules
ATC code N02AA N02AA
ATC description OPIOIDS OPIOIDS
Reason for shortage Other (Please describe in comments) Other (Please describe in comments)
Anticipated start date 2017-06-15 2017-06-15
Actual start date 2017-06-15 2017-06-15
Estimated end date 2017-12-31 2017-12-31
Actual end date
Shortage status Actual shortage Anticipated shortage
Company comments Inventory Constraints Inventory Constraints
Health Canada comments